IPO ROUND-UP: Adherium Inhales $25m As Summer Months See Deal Flow Slow To A Trickle
This article was originally published in Clinica
Executive Summary
Following the flurry of medtech IPOs in the first half of the year, the start of the second half saw a marked slump in deal flow, with August being particularly quiet.